Yazan al Homsi’s name has been showing up more often in clean-technology and healthcare coverage this year, mostly attached to the companies he backs rather than to himself. In June, Aduro Clean Technologies, one of the ventures in his portfolio, closed two capital raises totalling US$22.2 million within two weeks of each other and reported an 86 percent liquid hydrocarbon recovery rate from its pilot plant. For an investor whose public profile tends to track the fortunes of the businesses in his portfolio rather than his own activity, the recent run of milestones is a reasonable prompt to ask a more basic question: who is Yazan al Homsi, and how did he get here.
Al Homsi is the managing partner of Founders Round Capital, a Vancouver-based venture capital firm he founded in 2017, and Catalyst Communications DMCC, a Dubai-based firm he launched the following year. Together, the two firms anchor an investment career that has taken him from Saudi Arabia to Canada and the Gulf, and from Big Four consulting into small-cap venture investing focused on clean technology and healthcare artificial intelligence.
One disclosure before going further: al Homsi holds equity in Aduro Clean Technologies and Rocket Doctor AI, the two companies most closely tied to his name in this piece. That stake is the reason he has a documented investment record worth writing about in the first place, and it is stated here directly rather than left for a reader to assume.
Early Life and Education
Born in Saudi Arabia, al Homsi lived there until he was 11, when his family relocated to Canada, first to Toronto and later to Montreal. He returned to Saudi Arabia to finish his final two years of high school before coming back to Canada for university, enrolling at McGill University in Montreal. He graduated in 2004 with a bachelor’s degree in finance, in the top 5 percent of his class, having spent six months as an intern at General Motors during his studies.
His early career involved mixed corporate and entrepreneurial experience before he settled into finance. His first full-time job was as a sales representative at Imperial Oil’s Toronto office, a role he held for about a year and a half. He then co-founded a Montreal cafe-bistro called Cafe Noir, running it for roughly 14 months and picking up firsthand experience in staffing, operations and customer service, an early lesson in how a business actually runs day to day rather than how it looks on a balance sheet.
The bulk of al Homsi’s financial training came at PricewaterhouseCoopers, where he spent more than a decade in the Middle East. He joined the firm’s advisory practice as a senior consultant focused on mergers and acquisitions and initial public offerings, a role that took him to Saudi Arabia and the UAE. Over the following years, he was promoted to senior manager and then director, overseeing financial due diligence and valuation work across industries including retail, real estate, distribution, manufacturing and healthcare, and leading feasibility studies for projects across the Middle East and North Africa. He earned his Chartered Financial Analyst designation during this period, a credential that anchors much of how he is described in later coverage of his venture work.
Colleagues who have worked with al Homsi since his transition into venture investing point to that PwC decade as the source of a specific habit: treating management quality as a screening criterion in its own right, not just a footnote to the financials. The view, as he has put it in past interviews, is that execution capability separates companies that succeed from companies that simply have an interesting technology, and that spotting the difference requires direct relationships with founding teams rather than a purely numbers-driven review.
One deal is frequently cited as an early proof point for that judgment: Medicago, a Canadian plant-based vaccine developer, grew from a market capitalization of under US$10 million to US$357 million before drawing acquisition interest from Mitsubishi Pharma and Philip Morris in 2013. Al Homsi’s early involvement in the company’s growth trajectory is often referenced as the origin of his reputation for backing small, overlooked companies before they attract wider attention.
Building an Investment Career
Al Homsi returned to Canada in 2017 to launch Founders Round Capital, positioning the firm around small-cap companies transitioning from private ownership to public markets. The following year, he founded Catalyst Communications DMCC in Dubai, giving him an operating base in the Gulf alongside his Vancouver headquarters. He has described the dual presence less as a lifestyle choice than as a deal-flow advantage: maintaining direct exposure to regulatory developments, capital availability and technology maturation on two continents at once, rather than relying on secondary information about whichever market he isn’t standing in. In between building the two firms, he was active during Canada’s 2016 to 2018 cannabis legalization period, advising companies in the sector with an emphasis on sustainable business models over speculative license plays, a preference that has carried through into how he talks about every sector he has touched since.
Al Homsi has also become a visible advocate for folding environmental, social and governance considerations into small-cap investing, arguing that financial returns and positive impact are not mutually exclusive goals. A 2024 feature in The American Reporter positioned him among a cohort of investors pushing ESG integration further into mainstream venture practice, and that framing has stuck. Combined with his cross-border presence between Vancouver and Dubai, it has made him a recurring reference point in coverage of ESG-focused venture capital and cross-regional deal flow between North America and the Gulf, and a fixture of his public profile within that community.
Today, al Homsi’s portfolio centers on companies where he holds investor positions, not operating or partnership roles, a distinction he and his firms are consistent about across every piece of coverage involving his name. His current holdings include Aduro Clean Technologies, a chemical recycling company using patented water-based chemistry to process waste plastics, heavy bitumen and renewable oils, and Rocket Doctor AI, a physician-led virtual care platform that pairs a clinician marketplace with AI-assisted patient intake and documentation tools. Across those positions, al Homsi has described an investment framework built around a handful of criteria: defensible intellectual property, addressable markets measured in the billions rather than millions, management teams with a record of execution, and technologies aimed at documented market failures where regulation or economics already favor a solution.
That framework is also why the events of the past few weeks matter beyond Aduro’s own balance sheet. A clean, well-subscribed dual raise and a technical pilot-plant milestone are the kind of incremental, unglamorous proof points that Yazan al Homsi has said he looks for before a technology moves from promising to investable at scale, and they offer a more concrete way to evaluate his track record than his biography alone. Whether that track record extends to Aduro’s next phase, a first-of-a-kind commercial plant in the Netherlands, isn’t yet clear, though it’s likely to say more about al Homsi’s judgment than any single deal from his PwC years.
